Links
Organizations
Conferences
Info & Opinion
- Applied Clinical Trials
- Bio-IT World
- ClinPsych
- Clinical Trials Today
- Tom Lamb
- George Laszlo
- Pharma Voice
- Ed Silverman
- TJOLS
December 3, 2008
Thinking Beyond The Label
FDA On Drug Safety
A senior FDA official tells the Post-Approval Summit what the agency is going to do and would like to do in the post-Vioxx era.
- Home
- Tag
- sentinel
The recent Post-Approval Summit at Harvard, sponsored by technology firm Outcome, had several senior FDA speakers. Paul Seligman, associate director of safety policy and communication at the Center for Drug Evaluation and Research at FDA, addressed the thorny topic of…
No articles available
